title: Phase 1 clinical trials and toxicity.
authors.lastname: The Lancet Haematology
mesh_terms: D006801:Humans; D000077269:Lenalidomide; D008223:Lymphoma; D008495:Medical Oncology; D011687:Purines; D052999:Quinazolinones; D000069283:Rituximab
chemical_list: D011687:Purines; D052999:Quinazolinones; D000069283:Rituximab; D000077269:Lenalidomide; C552946:idelalisib